arrow
M

Michael G. Schlossmacher

University of Ottawa
H指数:56
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Parkinson’s disease-linked G2019S mutation of LRRK2 increases NADPH oxidase-2 activity in neutrophils for superior control of bacterial infections

帕金森病相关的LRRK2 G2019S突变通过增强中性粒细胞中NADPH氧化酶-2的活性来加强对细菌感染的控制

2026-07-170
PRE
Feasibility of Simon Two-Stage Futility Trials in People with Early, Symptomatically Treated Parkinson's Disease

早期、有症状治疗的帕金森病患者中Simon两阶段无效性试验的可行性

2025-10-200
OAAI
Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies

α-突触核蛋白种子在脑脊液中的定量测量有助于诊断synucleinopathies

2025-10-030
OA
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis
2024-10-070
PRE
Advancing Parkinson's Disease Research in Canada: The Canadian Open Parkinson Network (C-OPN) Cohort
2024-09-190
OAAI
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy
2024-04-041
OAAI
Parkin coregulates glutathione metabolism in adult mammalian brain

Parkin在成年哺乳动物大脑中调节谷胱甘肽代谢

2023-01-236
OAAI
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease
2021-07-2688
OAAI
Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites

与年龄相关的parkin在人中脑中的不溶性与氧化还原平衡和反应性多巴胺代谢产物的螯合有关

2021-03-1038
OAAI